RESUMEN
BACKGROUND AND PURPOSE: Concentrations of extracellular glycine in the CNS are regulated by two Na(+)/Cl(-) -dependent glycine transporters, GlyT1 and GlyT2. Selective inhibitors of GlyT1 have been developed for the treatment of schizophrenia, whilst selective inhibitors of GlyT2 are analgesic in animal models of pain. We have assessed a series of endogenous lipids as inhibitors of GlyT1 and GlyT2. EXPERIMENTAL APPROACH: Human GlyT1 and GlyT2 were expressed in Xenopus laevis oocytes, and the inhibitory actions of a series of acylcarnitines on glycine transport were measured using electrophysiological techniques. KEY RESULTS: Oleoyl-L-carnitine inhibited glycine transport by GlyT2, with an IC(50) of 340 nM, which is 15-fold more potent than the previously identified lipid inhibitor N-arachidonyl-glycine. Oleoyl-L-carnitine had a slow onset of inhibition and a slow washout. Using a series of chimeric GlyT1/2 transporters and point mutant transporters, we have identified an isoleucine residue in extracellular loop 4 of GlyT2 that conferred differences in sensitivity to oleoyl-L-carnitine between GlyT2 and GlyT1. CONCLUSIONS AND IMPLICATIONS: Oleoyl-L-carnitine is a potent non-competitive inhibitor of GlyT2. Previously identified GlyT2 inhibitors show potential as analgesics and the identification of oleoyl-L-carnitine as a novel GlyT2 inhibitor may lead to new ways of treating pain.
Asunto(s)
Carnitina/análogos & derivados , Proteínas de Transporte de Glicina en la Membrana Plasmática/antagonistas & inhibidores , Glicina/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Carnitina/química , Carnitina/farmacología , Relación Dosis-Respuesta a Droga , Proteínas de Transporte de Glicina en la Membrana Plasmática/genética , Estructura Molecular , Oocitos/metabolismo , Técnicas de Placa-Clamp , Xenopus laevisAsunto(s)
Colorantes Fluorescentes , Mycobacterium/aislamiento & purificación , Coloración y Etiquetado , Técnicas Histológicas , Humanos , Lepra/microbiología , Métodos , Músculo Liso/microbiología , Mycobacterium leprae/aislamiento & purificación , Mycobacterium tuberculosis/aislamiento & purificación , Parafina , Colorantes de RosanilinaAsunto(s)
Clofazimina/metabolismo , Tejido Adiposo/análisis , Glándulas Suprarrenales/análisis , Autopsia , Clofazimina/administración & dosificación , Clofazimina/análisis , Femenino , Vesícula Biliar/análisis , Humanos , Riñón/análisis , Lepra/tratamiento farmacológico , Hígado/análisis , Pulmón/análisis , Ganglios Linfáticos/análisis , Masculino , Tejido Nervioso/análisis , Páncreas/análisis , Piel/análisis , Espectrofotometría , Bazo/análisisRESUMEN
LIM (Lin-11, Isl-1, Mec-3), RING (Really interesting new gene), PHD (Plant homology domain) and MYND (myeloid, Nervy, DEAF-1) domains are all zinc-binding domains that ligate two zinc ions. Unlike the better known classical zinc fingers, these domains do not bind DNA, but instead mediate interactions with other proteins. LIM-domain containing proteins have diverse functions as regulators of gene expression, cell adhesion and motility and signal transduction. RING finger proteins are generally associated with ubiquitination; the presence of such a domain is the defining feature of a class of E3 ubiquitin protein ligases. PHD proteins have been associated with SUMOylation but most recently have emerged as a chromatin recognition motif that reads the methylation state of histones. The function of the MYND domain is less clear, but MYND domains are also found in proteins that have ubiquitin ligase and/or histone methyltransferase activity. Here we review the structure-function relationships for these domains and discuss strategies to modulate their activity.
Asunto(s)
Proteínas de Unión al ADN/fisiología , Proteínas de Homeodominio/fisiología , Dedos de Zinc/fisiología , Animales , Sitios de Unión , Proteínas de Unión al ADN/química , Proteínas de Homeodominio/química , Humanos , Conformación Proteica , Pliegue de Proteína , Dominios RING Finger/fisiología , Homología de Secuencia de AminoácidoRESUMEN
The objective of this paper is to encourage histopathologists to recognize and diagnose leprosy so that it can be treated effectively at the earliest stage possible, before irreversible deformities result. Recognition of the earliest form of leprosy-indeterminate-is emphasized. Histopathologic descriptions are made and illustrated for the principal types of leprosy. Emphasis is placed on (1) the need for dependable acid-fast staining of leprosy bacillus, (2) the non-specific infiltrate in indeterminate leprosy, and (3) the involvement of nerves in all types of leprosy.